tirzepatide vision loss Weight-loss drugs like semaglutide and linked to rare condition Could semaglutide drugs for diabetes,

Bratiotis 2009) 4 Causes and Risk Factors While the causes of OCD are not fully understood, several genetic, neurobiological, and environmental factors appear to be at least partially involved

Cardiovascular Safety Studies With DPP-4 Inhibitors The Clinical Guidance for Pharmaceutical IndustryDiabetes MellitusEvaluating Cardiovascular Risk in New Antidiabetic Therapies to Treat Type 2 Diabetes established by the FDA in 2008 as a consequence of adverse safety signals of rosiglitazone has set up the requirement for novel diabetes medications to prove cardiovascular safety of these substances in comparison to standard therapy under glycaemic equipoise

BMJ, 392, Article e085304

Although autonomic and peripheral GLP-1R+ neurons, including those within the nodose ganglion, may partially contribute to the weight loss actions of peripherally administered GLP-1RA [74, 82], ablation of CNS neurons targeted by nestin - Cre or Wnt1 - Cre abolishes the anorectic actions of peripherally administered GLP-1RA in mice [74, 83]